calendar
3,650 catalysts · 3,633 phase readout · 2,052 8k filing · 276 earnings · 172 phase 2 completion · 169 grant · 133 drug shortage
next 91 dayslessmore
MonWedFri
3,650 catalysts · 3,633 phase readout · 2,052 8k filing · 276 earnings · 172 phase 2 completion · 169 grant · 133 drug shortage
Therapy area: Metabolic Disorders. Indication: Type 2 Diabetes
Therapy area: Oncology. Indication: Chronic Myelomonocytic Leukemia (CMML)
Therapy area: Dermatology. Indication: Androgenic Alopecia
Therapy area: Central Nervous System, Mouth and Dental Disorders. Indication: Post-Operative Pain, Unspecified Mouth and Dental Disorders
Therapy area: Central Nervous System. Indication: Epilepsy
Therapy area: Central Nervous System. Indication: Post-Operative Pain
Therapy area: Metabolic Disorders. Indication: Type 2 Diabetes
Therapy area: Central Nervous System, Gastrointestinal, Genito Urinary System, Respiratory. Indication: Anorexia Nervosa, Unspecified Gastrointestinal Disorders, Unspecified Genito Urinary Disorders, Unspecified Respiratory Disorders
Therapy area: Infectious Disease. Indication: Rabies
Therapy area: Cardiovascular. Indication: Unspecified Cardiovascular Disorders
Therapy area: Oncology. Indication: Multiple Myeloma (Kahler Disease), Refractory Multiple Myeloma, Relapsed Multiple Myeloma
Sponsor: University of Alberta. Phase: . Conditions: Low Back Pain
Therapy area: Infectious Disease. Indication: Neisseria meningitidis Infections
Therapy area: Genito Urinary System, Infectious Disease. Indication: End-Stage Kidney Disease (End-Stage Renal Disease or ESRD), Unspecified Bacterial Infections
Therapy area: Hematological Disorders. Indication: Anemia, Iron Deficiency Anemia
Therapy area: Oncology. Indication: Nasopharyngeal Cancer
Therapy area: Central Nervous System, Musculoskeletal Disorders. Indication: Osteoarthritis, Post-Operative Pain
Therapy area: Genito Urinary System, Oncology. Indication: Bladder Cancer, Bladder Carcinoma, Kidney Cancer (Renal Cell Cancer), Metastatic Transitional (Urothelial) Tract Cancer, Renal Stones/Calculi, Transitional Cell Cancer (Urothelial Cell Cancer), Transitional Cell Carcinoma (Urothelial Cell Carcinoma), Ureter Cancer, Urethral Cancer
Sponsor: Beijing Sport University. Phase: NA. Conditions: Patellofemoral Pain
Sponsor: Definium Therapeutics US, Inc.. Phase: PHASE3. Conditions: Major Depressive Disorder
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Unresectable Melanoma
Sponsor: The University of Queensland. Phase: NA. Conditions: Blood Culture Contamination, Infection
Sponsor: Mayo Clinic. Phase: . Conditions: Spontaneous Coronary Artery Dissection
Sponsor: Riphah International University. Phase: NA. Conditions: Adhesive Capsulitis of the Shoulder
Sponsor: October 6 University. Phase: NA. Conditions: Cerebral Palsy
Sponsor: Liverpool School of Tropical Medicine. Phase: NA. Conditions: Crimean-Congo Haemorrhagic Fever
Sponsor: Eilean Therapeutics AU Pty Ltd. Phase: PHASE1. Conditions: Healthy Volunteers
Sponsor: Chandan Sen. Phase: NA. Conditions: Wound Heal, Wound Infection, Wound Healing Delayed, Wound of Skin, Infections
Sponsor: National Institute of Mental Health (NIMH). Phase: . Conditions: Neuropsychiatric Disorder, Neurological Disorder, Neurodevelopmental Disorder, Sleep
Sponsor: University of Washington. Phase: NA. Conditions: Mental Health Disorder
Sponsor: Nanchang University. Phase: NA. Conditions: Natural Orifice Specimen Extraction Surgery, Robotic Surgery, Short-term Outcomes
Sponsor: Mayo Clinic. Phase: PHASE4. Conditions: Endometrial Carcinoma
Sponsor: Alumis Inc. Phase: PHASE1. Conditions: Healthy Volunteer
Sponsor: Hu Liangshuo. Phase: . Conditions: Liver Transplantation, Hepatocellular Carcinoma (HCC), Tyrosine Kinase Inhibitor, Survival Rate
Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE2. Conditions: Immune Thrombocytopenia, Treatment
Sponsor: ECOG-ACRIN Cancer Research Group. Phase: PHASE2. Conditions: Melanoma of Unknown Primary, Metastatic Malignant Neoplasm in Lymph Node, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID Cutaneous Melanoma AJCC v8, Recurrent Cutaneous Melanoma
Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Systemic Lupus Erythematosus (SLE)
Sponsor: Asian Institute of Gastroenterology, India. Phase: NA. Conditions: Walled Off Necrosis
Sponsor: Echosens. Phase: NA. Conditions: Non-Alcoholic Fatty Liver Disease, Liver Disease; Alcohol-Related
Sponsor: Université de Reims Champagne-Ardenne. Phase: . Conditions: Human Immunodeficiency Virus (HIV)
Sponsor: Smith & Nephew, Inc.. Phase: . Conditions: Arthroplasty, Replacement, Knee
Sponsor: Iantrek, Inc.. Phase: . Conditions: Open-angle Glaucoma (OAG)
Sponsor: Balnear and Rehabilitation Sanatorium Techirghiol. Phase: NA. Conditions: Shoulder Tendinopathy
Sponsor: Florida A&M University. Phase: PHASE1. Conditions: Diabetic Peripheral Neuropathic Pain (DPN), Diabetic Neuropathies
Sponsor: Benha University. Phase: . Conditions: Lower Limb Fracture
Sponsor: Takeoff41, Inc.. Phase: NA. Conditions: Intestinal Failure
Sponsor: Guy's and St Thomas' NHS Foundation Trust. Phase: PHASE3. Conditions: Ischemic Heart Disease, Coronary Artery Disease
Sponsor: Eye & ENT Hospital of Fudan University. Phase: . Conditions: ORR, OS, PFS
Sponsor: University Children's Hospital, Zurich. Phase: . Conditions: Quality of Life, Stigmatization
Sponsor: French Innovative Leukemia Organisation. Phase: PHASE2. Conditions: Acute Myeloid Leukemia